Hillsdale Investment Management’s AdaptHealth AHCO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-368,400
Closed -$4.24M 576
2024
Q1
$4.24M Buy
+368,400
New +$3.13M 0.34% 109
2023
Q1
Sell
-67,340
Closed -$1.29M 554
2022
Q4
$1.29M Buy
+67,340
New +$1.42M 0.11% 168
2021
Q2
Sell
-28,800
Closed -$1.06M 564
2021
Q1
$1.06M Buy
28,800
+1,500
+5% +$53K 0.09% 240
2020
Q4
$1.02M Buy
+27,300
New +$845K 0.1% 214

Other funds holding AHCO

Hillsdale Investment Management's AHCO Position: Q2 2024 in Review

Hillsdale Investment Management sold out of AdaptHealth (AHCO) in Q2 2024, closing a stake of 368,400 shares — an estimated $4.24M sold.

Hillsdale Investment Management first reported a position in AHCO in Q4 2020 and held it in 4 quarters. The position peaked at $4.24M in Q1 2024. 207 funds tracked by Wall St. Rank hold AHCO as of Q2 2024.

  • Hillsdale Investment Management reported no remaining AdaptHealth position as of Q2 2024 after selling out during the quarter.
  • Hillsdale Investment Management sold 368,400 AdaptHealth shares in Q2 2024, an estimated $4.24M.
  • Hillsdale Investment Management first reported a position in AdaptHealth in Q4 2020 and held it in 4 quarters.
  • Hillsdale Investment Management's AdaptHealth position peaked at $4.24M in Q1 2024.
  • 207 funds tracked by Wall St. Rank held AdaptHealth as of Q2 2024.

Based on Hillsdale Investment Management's 13F filing for Q2 2024, filed 13 Aug 2024.